Cogent Biosciences Inc - Patients Treated With 100 Mg Bezuclastinib Showed Substantial Reduction in Their Most Severe Symptoms and Mast Cell Reactions
cogent biosciences公司-使用100毫克貝祖克拉斯替尼治療的患者顯示出其最嚴重症狀和肥大細胞反應有顯著減輕
Cogent Biosciences Inc - Patients Treated With 100 Mg Bezuclastinib Showed Substantial Reduction in Their Most Severe Symptoms and Mast Cell Reactions
cogent biosciences公司-使用100毫克貝祖克拉斯替尼治療的患者顯示出其最嚴重症狀和肥大細胞反應有顯著減輕
譯文內容由第三人軟體翻譯。